| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 6 707-711, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
RJ Weigel, DL Crooks, JD Iglehart and EC deConinck
Department of Surgery, Stanford University, California 94305, USA.
Recent studies have identified an estrogen receptor (ER) promoter upstream of the transcriptional start site originally mapped for the ER gene. We have examined promoter use in a number of breast carcinoma cell lines. MCF7, T47D, BT474, and MDA-MB-361 cell lines all use the P0 promoter, whereas BT20 and ZR75-1 do not demonstrate transcription from this upstream start site. S1 nuclease analysis was used to quantitate the amount of ER mRNA originating from the two different promoters. In MCF7, one-third of the ER mRNA results from transcription originating upstream of the major ER promoter and in T47D, 12% of the message originates from upstream transcription. Promoter use was analyzed in human mammary epithelial cells and human late proliferation endometrium. Upstream promoter use was found to be characteristic of human late proliferation endometrium but not human mammary epithelial cells. These results indicated that certain breast carcinomas demonstrate ER transcription from a promoter not normally active in normal breast epithelium. This activation may involve a factor active in normal human endometrium.
This article has been cited by other articles:
![]() |
M. Kos, S. Denger, G. Reid, and F. Gannon Upstream Open Reading Frames Regulate the Translation of the Multiple mRNA Variants of the Estrogen Receptor alpha J. Biol. Chem., September 27, 2002; 277(40): 37131 - 37138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kos, G. Reid, S. Denger, and F. Gannon Minireview: Genomic Organization of the Human ER{alpha} Gene Promoter Region Mol. Endocrinol., December 1, 2001; 15(12): 2057 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshida, H. Eguchi, K. Nakachi, K. Tanimoto, Y. Higashi, K. Suemasu, Y. Iino, Y. Morishita, and S.-i. Hayashi Distinct mechanisms of loss of estrogen receptor {{alpha}} gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors Carcinogenesis, December 1, 2000; 21(12): 2193 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Schuur and R. J. Weigel Monoallelic Amplification of Estrogen Receptor-{{alpha}} Expression in Breast Cancer Cancer Res., May 1, 2000; 60(10): 2598 - 2601. [Abstract] [Full Text] |
||||
![]() |
I. Treilleux, N. Peloux, M. Brown, and A. Sergeant Human Estrogen Receptor (ER) Gene Promoter-P1: Estradiol-Independent Activity and Estradiol Inducibility in ER+ and ER- Cells Mol. Endocrinol., August 1, 1997; 11(9): 1319 - 1331. [Abstract] [Full Text] |
||||
![]() |
E. R. Schuur, L. A. McPherson, G. P. Yang, and R. J. Weigel Genomic Structure of the Promoters of the Human Estrogen Receptor-alpha Gene Demonstrate Changes in Chromatin Structure Induced by AP2gamma J. Biol. Chem., April 27, 2001; 276(18): 15519 - 15526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |